- Report
- December 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- December 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- October 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- October 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- October 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- October 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- October 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- April 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- March 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- March 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- December 2024
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- August 2024
- 250 Pages
Global
From €3984EUR$4,450USD£3,393GBP
- Report
- April 2025
- 272 Pages
Global
From €3984EUR$4,450USD£3,393GBP
- Report
- March 2025
- 185 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- September 2024
- 200 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- April 2025
- 145 Pages
Global
From €2829EUR$3,160USD£2,410GBP
€3536EUR$3,950USD£3,012GBP
- Report
- March 2025
- 140 Pages
Global
From €2829EUR$3,160USD£2,410GBP
€3536EUR$3,950USD£3,012GBP
- Report
- December 2024
- 146 Pages
Global
From €2829EUR$3,160USD£2,410GBP
€3536EUR$3,950USD£3,012GBP
- Report
- August 2024
- 200 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- July 2024
- 200 Pages
Global
From €4430EUR$4,949USD£3,774GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more